利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

20 条记录 (耗时 0.022 秒)

    SYSTEMS AND METHODS TO OPTIMIZE ANTI-TACHYCARDIAL PACING (ATP)
    1.
    发明申请
    SYSTEMS AND METHODS TO OPTIMIZE ANTI-TACHYCARDIAL PACING (ATP) 审中-公开

    公开(公告)号：US20200009381A1

    公开(公告)日：2020-01-09

    申请号：US16512248

    申请日：2019-07-15

    申请人： CardioFlow Technologies, LLC

    发明人： Daniel Walter Kaiser

    IPC分类号： A61N1/362 ,  A61N1/365

    摘要： Apparatus, systems and methods are provided for prevention and/or remediation of cardiac arrhythmias, e.g. optimizing anti-tachycardia pacing (ATP) algorithms. More particularly, implantable devices are provided that measure and treat cardiac arrhythmias. By monitoring the ATP attempt from additional electrodes, far-field morphology analyses, and/or measuring the return interval from a failed ATP attempt; the devices may estimate when entrainment has occurred, the amount of delay within the reentrant tachycardia, and/or tachycardia termination/acceleration. These variables and occurrences can be used to optimize the first and/or subsequent ATP attempts. Furthermore, other exemplary embodiments describe methods to integrate electrical restitution properties into the design of ATP pacing algorithms to facilitate tachycardia termination.

    Apparatus and methods for optimizing volume status and cardiac output
    3.
    发明授权
    Apparatus and methods for optimizing volume status and cardiac output 有权

    公开(公告)号：US10987058B2

    公开(公告)日：2021-04-27

    申请号：US16042892

    申请日：2018-07-23

    申请人： CardioFlow Technologies, LLC

    发明人： Daniel Walter Kaiser

    IPC分类号： A61B5/00 ,  A61N1/365 ,  A61B5/02 ,  A61B5/029 ,  A61B5/026 ,  A61B5/0205 ,  A61B5/042 ,  A61B5/0215 ,  A61N1/05 ,  A61M25/00

    摘要： Systems and methods are provided for optimizing hemodynamics within a patient. Specifically, the system incorporates invasive sensor data (e.g., pressure measurements) combined with mechanisms to dynamically change the loading conditions of the heart and/or heart rate, in order to understand hemodynamic parameters. Computational analyses on dynamic sensor data are used to understand and guide heart rate, filling pressures, and/or volume resuscitation in critically ill patients. By pacing the heart or inducing tricuspid regurgitation, the system may cause dynamic changes in sensor data to understand optimal loading conditions and heart rates. While determining optimal hemodynamic parameters, the system may then automatically optimize the heart rate and/or filling pressures in critically ill patients.

    SYSTEMS AND METHODS TO OPTIMIZE ANTI-TACHYCARDIAL PACING (ATP)
    7.
    发明申请
    SYSTEMS AND METHODS TO OPTIMIZE ANTI-TACHYCARDIAL PACING (ATP) 审中-公开

    公开(公告)号：US20180117325A1

    公开(公告)日：2018-05-03

    申请号：US15791043

    申请日：2017-10-23

    申请人： CardioFlow Technologies, LLC

    发明人： Daniel Walter Kaiser

    IPC分类号： A61N1/362 ,  A61N1/365 ,  A61B5/0464 ,  A61B5/00

    CPC分类号： A61N1/3622 ,  A61B5/0464 ,  A61B5/7282 ,  A61N1/36514

    摘要： Apparatus, systems and methods are provided for prevention and/or remediation of cardiac arrhythmias, e.g. optimizing anti-tachycardia pacing (ATP) algorithms. More particularly, implantable devices are provided that measure and treat cardiac arrhythmias. By monitoring the ATP attempt from additional electrodes, far-field morphology analyses, and/or measuring the return interval from a failed ATP attempt; the devices may estimate when entrainment has occurred, the amount of delay within the reentrant tachycardia, and/or tachycardia termination/acceleration. These variables and occurrences can be used to optimize the first and/or subsequent ATP attempts. Furthermore, other exemplary embodiments describe methods to integrate electrical restitution properties into the design of ATP pacing algorithms to facilitate tachycardia termination.

    SYSTEMS AND METHODS TO OPTIMIZE ANTI-TACHYCARDIAL PACING (ATP)
    8.
    发明申请
    SYSTEMS AND METHODS TO OPTIMIZE ANTI-TACHYCARDIAL PACING (ATP) 审中-公开
    优化抗胃酸肽（ATP）的系统和方法

    公开(公告)号：US20160030743A1

    公开(公告)日：2016-02-04

    申请号：US14811719

    申请日：2015-07-28

    申请人： CardioFlow Technologies, LLC

    发明人： Daniel Walter Kaiser

    IPC分类号： A61N1/362 ,  A61N1/365

    CPC分类号： A61N1/3622 ,  A61B5/0464 ,  A61B5/7282 ,  A61N1/36514

    摘要： Apparatus, systems and methods are provided for prevention and/or remediation of cardiac arrhythmias, e.g. optimizing anti-tachycardia pacing (ATP) algorithms. More particularly, implantable devices are provided that measure and treat cardiac arrhythmias. By monitoring the ATP attempt from additional electrodes, far-field morphology analyses, and/or measuring the return interval from a failed ATP attempt; the devices may estimate when entrainment has occurred, the amount of delay within the reentrant tachycardia, and/or tachycardia termination/acceleration. These variables and occurrences can be used to optimize the first and/or subsequent ATP attempts. Furthermore, other exemplary embodiments describe methods to integrate electrical restitution properties into the design of ATP pacing algorithms to facilitate tachycardia termination.

    摘要翻译： 提供了用于预防和/或修复心律失常的装置，系统和方法，例如， 优化抗心动过速起搏（ATP）算法。 更具体地，提供了可测量和治疗心律失常的可植入装置。 通过监测来自附加电极的ATP尝试，远场形态分析和/或测量从失败的ATP尝试的返回间隔; 装置可以估计何时发生夹带，折返性心动过速中的延迟量和/或心动过速终止/加速。 这些变量和事件可用于优化第一次和/或其后的ATP尝试。 此外，其他示例性实施例描述了将电恢复特性整合到ATP起搏算法的设计中以促进心动过速终止的方法。

    Systems and methods to optimize anti-tachycardial pacing (ATP)
    10.
    发明授权
    Systems and methods to optimize anti-tachycardial pacing (ATP) 有权

    公开(公告)号：US10350415B2

    公开(公告)日：2019-07-16

    申请号：US15791043

    申请日：2017-10-23

    申请人： CardioFlow Technologies, LLC

    发明人： Daniel Walter Kaiser

    IPC分类号： A61B5/00 ,  A61N1/365 ,  A61B5/0464 ,  A61N1/362

    摘要： Apparatus, systems and methods are provided for prevention and/or remediation of cardiac arrhythmias, e.g. optimizing anti-tachycardia pacing (ATP) algorithms. More particularly, implantable devices are provided that measure and treat cardiac arrhythmias. By monitoring the ATP attempt from additional electrodes, far-field morphology analyzes, and/or measuring the return interval from a failed ATP attempt; the devices may estimate when entrainment has occurred, the amount of delay within the reentrant tachycardia, and/or tachycardia termination/acceleration. These variables and occurrences can be used to optimize the first and/or subsequent ATP attempts. Furthermore, other exemplary embodiments describe methods to integrate electrical restitution properties into the design of ATP pacing algorithms to facilitate tachycardia termination.